The Second Affiliated Hospital of Nanjing Medical University — Biomedical Watch V2

Essais liés8clinical trials

VilleNanjinglocalisation

PaysChinalocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT07361302

Ouvrir le site du centre

Essais cliniques associés

8

Molécule	Indication / population	Phase	NCT	Titre	Statut
Survodutide	Maladie rénale chronique	Phase 3	NCT06077864	A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)	COMPLETED
Maridebart cafraglutide	Insuffisance cardiaque	Phase 3	NCT07037459	MARITIME-HF — Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity	RECRUITING
Survodutide	Maladie coronarienne	Phase 3	NCT07850063	ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease	NOT_YET_RECRUITING
Tenecteplase	Accident vasculaire cérébral	Phase 3	NCT07361302	TENACITY — A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given More Than 4.5 Hours After the Person Was Last Seen Well	RECRUITING
Trontinemab	Alzheimer	Phase 3	NCT07717411	PrevenTRON — A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease	RECRUITING
Rimegepant	Migraine	Phase 3	NCT05810038	A Study to Learn About the Safety and Effects of Rimegepant to Prevent Migraine in Chinese Subjects.	COMPLETED
Vicadrostat	Hypertension	Phase 3	NCT07064473	EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	RECRUITING
Rimegepant	Migraine	Phase 3	NCT06641466	A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine	RECRUITING